VEGFA and colorectal cancer: This reduced glycolytic capacity leads to decreased expression of VEGF in colorectal cancer cells, which in turn reduces neovascularization and vascular permeability in liver metastases, ultimately resulting in a decreased occurrence of liver metastasis.